Labetalol injection contraindications: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Labetalol}} {{CMG}}; {{AE}} {{SS}} ==Contraindications== Labetalol HCl injection is contraindicated in bronchial asthma, overt cardiac failure, greater than f...")
 
No edit summary
Line 7: Line 7:


Beta-blockers, even those with apparent cardioselectivity, should not be used in patients with a history of obstructive airway disease, including [[asthma]].
Beta-blockers, even those with apparent cardioselectivity, should not be used in patients with a history of obstructive airway disease, including [[asthma]].
==References==
{{Reflist|2}}
[[Category:Beta blockers]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Revision as of 17:56, 5 February 2014

Labetalol
LABETALOL tablet® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
LABETALOL injection® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Labetalol
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Contraindications

Labetalol HCl injection is contraindicated in bronchial asthma, overt cardiac failure, greater than first degree heart block, cardiogenic shock, severe bradycardia, other conditions associated with severe and prolonged hypotension, and in patients with a history of hypersensitivity to any component of the product (see WARNINGS).

Beta-blockers, even those with apparent cardioselectivity, should not be used in patients with a history of obstructive airway disease, including asthma.



References

Template:WikiDoc Sources